The therapeutic value of targeting inflammation in gastrointestinal cancers

Trends in Pharmacological Sciences

Volumn 35, Issue 7, 2014, Pages 349-357

  Sun, Beicheng ^a   Karin, Michael ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cytokines; targeting therapy; tumor initiation; tumor promotion

Indexed keywords

BEVACIZUMAB; CETUXIMAB; CHEMOKINE RECEPTOR; GOLNERMINOGENE PRADENOVEC; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; INTERLEUKIN 11; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 6; MERCAPTOPURINE; PANITUMUMAB; PROTEASOME INHIBITOR; SILTUXIMAB; SORAFENIB; STAT3 PROTEIN; TOCILIZUMAB; TRANSCRIPTION FACTOR AP 1; TRASTUZUMAB; TUMOR NECROSIS FACTOR; ZOLEDRONIC ACID;

CANCER GROWTH; CANCER LOCALIZATION; CANCER RESISTANCE; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DRUG TARGETING; HOST RESISTANCE; HUMAN; INFLAMMATION; INFLAMMATORY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TUMOR ESCAPE; TUMOR PROMOTION; TUMOR REGRESSION;

CYTOKINES; TARGETING THERAPY; TUMOR INITIATION; TUMOR PROMOTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; GASTROINTESTINAL NEOPLASMS; HUMANS; INFLAMMATION;

EID: 84903381578     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2014.04.011     Document Type: Review

References (104)

1. A. Jemal et al. Global cancer statistics CA: Cancer J. Clin. 61 2011 69 90
2. F. Balkwill, and A. Mantovani Inflammation and cancer: back to Virchow? Lancet 357 2001 539 545 (Pubitemid 32173595)
3. S.I. Grivennikov et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth Nature 491 2012 254 258
4. C. Jobin Colorectal cancer: CRC - all about microbial products and barrier function? Nat. Rev. Gastroenterol. Hepatol. 9 2012 694 696
5. C.L. Sears, and W.S. Garrett Microbes, microbiota, and colon cancer Cell Host Microbe 15 2014 317 328
6. A. Mantovani et al. Cancer-related inflammation Nature 454 2008 436 444
7. S.I. Grivennikov et al. Immunity, inflammation, and cancer Cell 140 2010 883 899
8. J.L. Ren et al. Inflammatory signaling and cellular senescence Cell. Signal. 21 2009 378 383
9. J.K. Kundu, and Y.J. Surh Inflammation: gearing the journey to cancer Mutat. Res. 659 2008 15 30
10. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867 (Pubitemid 36019639)
11. F. Balkwill Cancer and the chemokine network Nat. Rev. Cancer 4 2004 540 550 (Pubitemid 38868623)
12. H. Bartsch, and J. Nair Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair Langenbecks Arch. Surg. 391 2006 499 510 (Pubitemid 44337612)
13. S. Reuter et al. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic. Biol. Med. 49 2010 1603 1616
14. R. Zhang et al. Oxidative stress causes epigenetic alteration of CDX1 expression in colorectal cancer cells Gene 524 2013 214 219
15. T. Sawa, and H. Ohshima Nitrative DNA damage in inflammation and its possible role in carcinogenesis Nitric Oxide 14 2006 91 100 (Pubitemid 43165874)
16. H. Shaked et al. Chronic epithelial NF-κB activation accelerates APC loss and intestinal tumor initiation through iNOS up-regulation Proc. Natl. Acad. Sci. U.S.A. 109 2012 14007 14012
17. J.K. Dyson, and M.D. Rutter Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk? World J. Gastroenterol. 18 2012 3839 3848
18. C. Pohl et al. Chronic inflammatory bowel disease and cancer Hepatogastroenterology 47 2000 57 70 (Pubitemid 30085390)
19. + Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer Gut 63 2014 761 770
20. M. Li et al. Helicobacter pylori infection synergizes with three inflammation-related genetic variants in the GWASs to increase risk of gastric cancer in a Chinese population PLoS ONE 8 2013 e74976
21. M. Teh et al. Study of p53 immunostaining in the gastric epithelium of cagA-positive and cagA-negative Helicobacter pylori gastritis Cancer 95 2002 499 505 (Pubitemid 34810174)
22. O. Hammam et al. A possible role for TNF-α in coordinating inflammation and angiogenesis in chronic liver disease and hepatocellular carcinoma Gastrointest. Cancer Res. 6 2013 107 114
23. W.E. Naugler et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production Science 317 2007 121 124 (Pubitemid 47056470)
24. G. He et al. Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling Cell 155 2013 384 396
25. T. Sakurai et al. Hepatocyte necrosis induced by oxidative stress and IL-1α release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis Cancer Cell 14 2008 156 165
26. M. Nukaya et al. The aryl hydrocarbon receptor-interacting protein (AIP) is required for dioxin-induced hepatotoxicity but not for the induction of the Cyp1a1 and Cyp1a2 genes J. Biol. Chem. 285 2010 35599 35605
27. R. Eferl, and E.F. Wagner AP-1: a double-edged sword in tumorigenesis Nat. Rev. Cancer 3 2003 859 868 (Pubitemid 37383716)
28. S.I. Grivennikov, and M. Karin Dangerous liaisons: STAT3 and NF-κB coll-aboration and crosstalk in cancer Cytokine Growth Factor Rev. 21 2010 11 19
29. J.A. Burger, and T.J. Kipps CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment Blood 107 2006 1761 1767 (Pubitemid 43289351)
30. A. Mantovani et al. The chemokine system in cancer biology and therapy Cytokine Growth Factor Rev. 21 2010 27 39
31. C.C. Schimanski et al. Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer Clin. Cancer Res. 11 2005 1743 1750 (Pubitemid 40471835)
32. D. Hu et al. The expression of chemokine receptors CCR6, CXCR2 and CXCR4 is not organ-specific for distant metastasis in colorectal cancer: a comparative study Histopathology 63 2013 167 173
33. H. Kulbe et al. The inflammatory cytokine tumor necrosis factor-α regulates chemokine receptor expression on ovarian cancer cells Cancer Res. 65 2005 10355 10362 (Pubitemid 41743728)
34. K.A. Manu et al. Emodin suppresses migration and invasion through the modulation of CXCR4 expression in an orthotopic model of human hepatocellular carcinoma PLoS ONE 8 2013 e57015
35. R.C. Bates, and A.M. Mercurio Tumor necrosis factor-α stimulates the epithelial-to-mesenchymal transition of human colonic organoids Mol. Biol. Cell 14 2003 1790 1800 (Pubitemid 36583533)
36. C.E. Clark et al. Immunosurveillance of pancreatic adenocarcinoma: insights from genetically engineered mouse models of cancer Cancer Lett. 279 2009 1 7
37. Y. Pylayeva-Gupta et al. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia Cancer Cell 21 2012 836 847
38. R.F. Schwabe, and C. Jobin The microbiome and cancer Nat. Rev. Cancer 13 2013 800 812
39. C.E. Lewis, and J.W. Pollard Distinct role of macrophages in different tumor microenvironments Cancer Res. 66 2006 605 612 (Pubitemid 43165918)
40. S.B. Coffelt et al. Tumor-associated macrophages: effectors of angiogenesis and tumor progression Biochim. Biophys. Acta 1796 2009 11 18
41. M. De Palma et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors Cancer Cell 8 2005 211 226 (Pubitemid 41317592)
42. A. Sica et al. Macrophage polarization in tumour progression Semin. Cancer Biol. 18 2008 349 355
43. H. Shime et al. Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway J. Immunol. 180 2008 7175 7183
44. J. Li et al. Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-κB induced matrix metalloproteinase 9 expression PLoS ONE 7 2012 e46264
45. M. Karin et al. Chemotherapy, immunity and microbiota - a new triumvirate? Nat. Med. 20 2014 126 127
46. Z. Shen et al. The novel focal adhesion gene kindlin-2 promotes the invasion of gastric cancer cells mediated by tumor-associated macrophages Oncol. Rep. 29 2013 791 797
47. D. Capece et al. The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages Biomed Res. Int. 2013 2013 187204
48. K. Shirabe et al. Role of tumor-associated macrophages in the progression of hepatocellular carcinoma Surg. Today 42 2012 1 7
49. W. Zhang et al. Depletion of tumor-associated macrophages enhances the effect of sorafenib in metastatic liver cancer models by antimetastatic and antiangiogenic effects Clin. Cancer Res. 16 2010 3420 3430
50. A.P. Vicari et al. Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody J. Exp. Med. 196 2002 541 549
51. + T cells Oncoimmunology 1 2012 1637 1639
52. W.W. Lin, and M. Karin A cytokine-mediated link between innate immunity, inflammation, and cancer J. Clin. Invest. 117 2007 1175 1183 (Pubitemid 46718402)
53. K. Takeuchi et al. Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease Clin. Gastroenterol. Hepatol. 4 2006 196 202 (Pubitemid 43199690)
54. E. Barbera-Guillem et al. B lymphocyte pathology in human colorectal cancer. Experimental and clinical therapeutic effects of partial B cell depletion Cancer Immunol. Immunother. 48 2000 541 549 (Pubitemid 30004488)
55. J. Cany et al. Immunotherapy of hepatocellular carcinoma: is there a place for regulatory T-lymphocyte depletion? Immunotherapy 3 2011 32 34
56. M. Kujawski et al. Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice J. Clin. Invest. 118 2008 3367 3377
57. + myeloid cells Nat. Biotechnol. 25 2007 911 920 (Pubitemid 47236916)
58. E. Maniati, and T. Hagemann IL-17 mediates resistance to anti-VEGF therapy Nat. Med. 19 2013 1092 1094
59. S. Grivennikov et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer Cancer Cell 15 2009 103 113
60. T.L. Putoczki et al. Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically Cancer Cell 24 2013 257 271
61. J. Yang et al. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFκB Genes Dev. 21 2007 1396 1408 (Pubitemid 46871042)
62. S. Grivennikov, and M. Karin Autocrine IL-6 signaling: a key event in tumorigenesis? Cancer Cell 13 2008 7 9 (Pubitemid 350309747)
63. K. Taniguchi, and M. Karin IL-6 and related cytokines as the critical lynchpins between inflammation and cancer Semin. Immunol. 26 2014 54 74
64. S.I. Grivennikov IL-11: a prominent pro-tumorigenic member of the IL-6 family Cancer Cell 24 2013 145 147
65. K. Wang et al. Implications of anti-cytokine therapy in colorectal cancer and autoimmune diseases Ann. Rheum. Dis. 72 Suppl. 2 2013 ii100 ii103
66. S. Huber et al. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine Nature 491 2012 259 263
67. Y. Krelin et al. Interleukin-1β-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors Cancer Res. 67 2007 1062 1071
68. L.C. Hsu et al. IL-1β-driven neutrophilia preserves antibacterial defense in the absence of the kinase IKKβ Nat. Immunol. 12 2011 144 150
69. R.A. Gupta, and R.N. Dubois Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2 Nat. Rev. Cancer 1 2001 11 21 (Pubitemid 33741877)
70. A. Nasir et al. COX-2, NSAIDs and human neoplasia. Part I: colorectal neoplasms In Vivo 16 2002 501 509 (Pubitemid 35476778)
71. J.M. Luk et al. DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival J. Biol. Chem. 286 2011 30706 30713
72. Z. Chen et al. Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma Cancer 119 2013 1985 1993
73. A. Petrelli et al. MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC) Hepatology 59 2014 228 241
74. H.L. Lin et al. 2-Methoxyestradiol attenuates phosphatidylinositol 3-kinase/Akt pathway-mediated metastasis of gastric cancer Int. J. Cancer 121 2007 2547 2555
75. J.F. Bromberg et al. Stat3 as an oncogene Cell 98 1999 295 303 (Pubitemid 29380565)
76. E. Pikarsky et al. NF-κB functions as a tumour promoter in inflammation-associated cancer Nature 431 2004 461 466 (Pubitemid 39329586)
77. J.A. DiDonato et al. NF-κB and the link between inflammation and cancer Immunol. Rev. 246 2012 379 400
78. T. Cooks et al. Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer Cancer Cell 23 2013 634 646
79. Y. Endo et al. Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers Gastroenterology 135 2008 889 898
80. K.B. Myant et al. ROS production and NF-κB activation triggered by RAC1 facilitate WNT-driven intestinal stem cell proliferation and colorectal cancer initiation Cell Stem Cell 12 2013 761 773
81. S. Schwitalla et al. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties Cell 152 2013 25 38
82. F.R. Greten et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer Cell 118 2004 285 296 (Pubitemid 39061110)
83. M.J. Yin et al. The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β Nature 396 1998 77 80
84. S. Amit, and Y. Ben-Neriah NF-κB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach Semin. Cancer Biol. 13 2003 15 28 (Pubitemid 36269177)
85. T.P. van Staa et al. 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study Gut 54 2005 1573 1578 (Pubitemid 41531774)
86. C. Stolfi et al. Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and mesalazine in the chemoprevention of colorectal cancer Int. J. Mol. Sci. 14 2013 17972 17985
87. A.N. Ananthakrishnan et al. Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study Ann. Intern. Med. 156 2012 350 359
88. F.R. Greten, and M. Karin The IKK/NF-κB activation pathway - a target for prevention and treatment of cancer Cancer Lett. 206 2004 193 199 (Pubitemid 38317289)
89. K.S. Ahn et al. Guggulsterone, a farnesoid X receptor antagonist, inhibits constitutive and inducible STAT3 activation through induction of a protein tyrosine phosphatase SHP-1 Cancer Res. 68 2008 4406 4415
90. A.C. Bharti et al. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells J. Immunol. 171 2003 3863 3871 (Pubitemid 37254592)
91. S.K. Manna et al. Silymarin suppresses TNF-induced activation of NF-κB, c-Jun N-terminal kinase, and apoptosis J. Immunol. 163 1999 6800 6809
92. H. Yu et al. STATs in cancer inflammation and immunity: a leading role for STAT3 Nat. Rev. Cancer 9 2009 798 809
93. H. Tye et al. STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation Cancer Cell 22 2012 466 478
94. J. Hou et al. Estrogen-sensitive PTPRO expression represses hepatocellular carcinoma progression by control of STAT3 Hepatology 57 2013 678 688
95. C.A. Stewart, and G. Trinchieri Reinforcing suppression using regulators: a new link between STAT3, IL-23, and Tregs in tumor immunosuppression Cancer Cell 15 2009 81 83
96. M. Kortylewski et al. Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment Cancer Cell 15 2009 114 123
97. Y. Fan et al. NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer Protein Cell 4 2013 176 185
98. R.A. Mesa Ruxolitinib, a selective JAK1 and JAK2 inhibitor for the treatment of myeloproliferative neoplasms and psoriasis IDrugs 13 2010 394 403
99. M. Hedvat et al. The JAK2 inhibitor AZD1480 potently blocks Stat3 signaling and oncogenesis in solid tumors Cancer Cell 16 2009 487 497
100. M.R. Alison Liver stem cells: implications for hepatocarcinogenesis Stem Cell Rev. 1 2005 253 260 (Pubitemid 41737102)
101. high metastatic subset in HCT116 colon cancer cells Clin. Exp. Metastasis 28 2011 751 763
102. W. Zhang et al. A NIK-IKKα module expands ErbB2-induced tumor-initiating cells by stimulating nuclear export of p27/Kip1 Cancer Cell 23 2013 647 659
103. H. Obokata et al. Stimulus-triggered fate conversion of somatic cells into pluripotency Nature 505 2014 641 647
104. H. Obokata et al. Bidirectional developmental potential in reprogrammed cells with acquired pluripotency Nature 505 2014 676 680